Suchergebnisse - "Sturdy, Ann"

PubPharm (15)

1

Centralising human resources paperwork would improve rotational training

enthalten in: BMJ (Clinical research ed.) | 2024

von Sturdy, A.

CommentOn: BMJ. 2024 Feb 29;384:q410. - PMID 38423581

2

A Systematic Review on the Effect of Diabetes Mellitus on the Pharmacokinetics of Tuberculosis Drugs

enthalten in: bioRxiv.org | 2024

von Cevik, M. | Sturdy, A. | Maraolo, A. | +4

3

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK : a retrospective cohort study

enthalten in: The Lancet. Infectious diseases | 2023

von Fink, D. | Callaby, H. | Luintel, A. | +134

CommentIn: Lancet Infect Dis. 2023 May;23(5):516-517. - PMID 36566770

4

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511

enthalten in: The Journal of infection | 2023

von Liu, X. | Munro, A. | Feng, S. | +56

ErratumFor: J Infect. 2022 Jun;84(6):795-813. - PMID 35405168

5

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST) : a multicentre, blinded, phase 2, randomised trial

enthalten in: The Lancet. Infectious diseases | 2022

von Munro, A. | Feng, S. | Janani, L. | +153

CommentIn: Lancet Infect Dis. 2022 Aug;22(8):1092-1093. - PMID 35550263

6

Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T-cell leukaemia virus type-1 and type-2 infection in a London teaching hospital with a large solid organ transplant centre

enthalten in: Transfusion medicine (Oxford, England) | 2022

von Lee, N. | Murphy, J. | Al-Khudairi, R. | +6

7

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK : Three month analyses of the COV-BOOST trial

enthalten in: The Journal of infection | 2022

von Liu, X. | Munro, A. | Feng, S. | +56

CommentIn: J Infect. 2023 Feb;86(2):154-225. - PMID 36509358

8

Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre

enthalten in: Transfusion Medicine | 2022

von Lee, N. | Murphy, J. | Al‐Khudairi, R. | +6

9

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST) : a blinded, multicentre, randomised, controlled, phase 2 trial

enthalten in: Lancet (London, England) | 2021

von Munro, A. | Janani, L. | Cornelius, V. | +152

ErratumIn: Lancet. 2021 Dec 18;398(10318):2246. - PMID 34922669

10

Case of eosinophilic fasciitis during military training in a Nepalese British infantry soldier

enthalten in: BMJ military health | 2020

von Sturdy, A. | Stratton, R. | Perez-Machado, M. | +1